The effect of Barlow's unified protocol for transdiagnostic treatment on emotional symptoms, pain catastrophizing, fear of movement and disease activity in patients with rheumatoid arthritis

Not Applicable

• Conditions: Rheumatoid arthritis.; Rheumatoid arthritis, unspecified; M06.9

• Registration Number: IRCT20231210060327N1
• Lead Sponsor: Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 27 May 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 52

Inclusion Criteria

Age range from 18 to 60 years old
Rheumatoid arthritis has been diagnosed by a specialist
At least 6 months have passed since the diagnosis of the disease by a specialist
There is no other psychological illness at the same time
Informed consent to participate in the research
Keeping the type and amount of drug used constant during the research period
Education level of at least fifth grade

Exclusion Criteria

The presence of any chronic physical disease such as cancer and MS at the same time, except for rheumatoid arthritis
Drug use
Alcohol consumption
Absence in more than two meetings
Lack of participation and homework
The appearance of suicidal thoughts or the experience of the death of a loved one
Taking antidepressants and anti-anxiety drugs

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Emotional symptoms (stress,anxiety,depression). Timepoint: At the beginning of the study, after the end of the intervention. Method of measurement: Questionnaire DASS-21.;Pain catastrophizing. Timepoint: At the beginning of the study, after the end of the intervention. Method of measurement: PCS questionnaire.;Fear of movement. Timepoint: At the beginning of the study, after the end of the intervention. Method of measurement: Tampa questionnaire.;Disease activity. Timepoint: At the beginning of the study, after the end of the intervention. Method of measurement: DAS-28 questionnaire.;Difficulty regulating emotions. Timepoint: At the beginning of the study, after the end of the intervention. Method of measurement: DERS questionnaire.